Bilaketaren emaitzak - Andrea Pretta
- Erakusten 1 - 9 emaitzak -- 9
-
1
How to improve metastatic pancreatic ductal adenocarcinoma patients’ selection: Between clinical trials and the real-world nork Andrea Pretta, Dario Spanu, Stefano Mariani, Nicole Liscia, Pina Ziranu, Valeria Pusceddu, Marco Puzzoni, Elena Massa, Mario Scartozzi, Eleonora Lai
Argitaratua 2022Artigo -
2
-
3
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advance... nork Clelia Madeddu, Sı́lvia Busquets, Clelia Donisi, Eleonora Lai, Andrea Pretta, Francisco J. López‐Soriano, Josep M. Argilés, Mario Scartozzi, Antonio Macciò
Argitaratua 2023Artigo -
4
Immune Checkpoint Inhibitors in the Treatment of HCC nork Clelia Donisi, Marco Puzzoni, Pina Ziranu, Eleonora Lai, Stefano Mariani, Giorgio Saba, Valentino Impera, Marco Dubois, Mara Persano, Marco Migliari, Andrea Pretta, Nicole Liscia, Giorgio Astara, Mario Scartozzi
Argitaratua 2021Revisão -
5
BRCA-mutant pancreatic ductal adenocarcinoma nork Eleonora Lai, Pina Ziranu, Dario Spanu, Marco Dubois, Andrea Pretta, S. Tolu, Silvia Camera, Nicole Liscia, Stefano Mariani, Mara Persano, Marco Migliari, Clelia Donisi, Laura Demurtas, Valeria Pusceddu, Marco Puzzoni, Mario Scartozzi
Argitaratua 2021Revisão -
6
New therapeutic targets in pancreatic cancer nork Eleonora Lai, Marco Puzzoni, Pina Ziranu, Andrea Pretta, Valentino Impera, Stefano Mariani, Nicole Liscia, P Soro, Francesca Musio, Mara Persano, Clelia Donisi, S. Tolu, Francesca Balconi, Annagrazia Pireddu, Laura Demurtas, Valeria Pusceddu, Silvia Camera, Francesco Sclafani, Mario Scartozzi
Argitaratua 2019Revisão -
7
CD44: A New Prognostic Marker in Colorectal Cancer? nork Pina Ziranu, Andrea Pretta, Valentina Aimola, Flaviana Cau, Stefano Mariani, Alessandra Pia D’Agata, Claudia Codipietro, Daiana Rizzo, Veronica Dell’Utri, Giorgia Sanna, Giusy Moledda, Andrea Cadoni, Eleonora Lai, Marco Puzzoni, Valeria Pusceddu, Massimo Castagnola, Mario Scartozzi, Gavino Faa
Argitaratua 2024Artigo -
8
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma nork Letizia Procaccio, Valeria Merz, Morena Fasano, Vanja Vaccaro, Elisa Giommoni, Andrea Pretta, Silvia Noventa, Maria Antonietta Satolli, Guido Giordano, Clizia Zichi, Carmine Pinto, Camilla Zecchetto, Giulia Barsotti, Ferdinando De Vita, Michèle Milella, Lorenzo Antonuzzo, Mario Scartozzi, Alberto Zaniboni, Rosella Spadi, Simona Casalino, Francesca Bergamo, Chiara De Toni, Davide Melisi, Sara Lonardi
Argitaratua 2023Artigo -
9
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data nork Margherita Rimini, Lorenzo Fornaro, Sara Lonardi, Monica Niger, Daniele Lavacchi, Tiziana Pressiani, Jessica Lucchetti, Guido Giordano, Andrea Pretta, Emiliano Tamburini, Chiara Pirrone, Ilario Giovanni Rapposelli, Anna Diana, Erika Martinelli, Ingrid Garajová, Francesca Simionato, Marta Schirripa, Vincenzo Formica, Caterina Vivaldi, Enrico Caliman, Mario Domenico Rizzato, Valentina Zanuso, Federico Nichetti, Lorenzo Angotti, Matteo Landriscina, Mario Scartozzi, Matteo Ramundo, Alessandro Pastorino, Bruno Daniele, Noemi Cornara, Mara Persano, Eleonora Gusmaroli, Riccardo Cerantola, Francesca Salani, Francesca Ratti, Luca Aldrighetti, Stefano Cascinu, Lorenza Rimassa, Lorenzo Antonuzzo, Andrea Casadei‐Gardini
Argitaratua 2023Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Cancer
Internal medicine
Medicine
Oncology
Biology
Cancer research
Chemotherapy
Immunotherapy
Pancreatic cancer
Gastroenterology
Gemcitabine
Colorectal cancer
Context (archaeology)
Gene
Genetics
Immune checkpoint
Immune system
Immunology
Irinotecan
Nivolumab
Paleontology
Adenocarcinoma
Alternative splicing
Antibody
Atezolizumab
BRCA2 Protein
Bevacizumab
Biliary tract
Biliary tract cancer
Bioinformatics